These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29162395)

  • 1. Automated red blood cell depletion in ABO incompatible grafts in the pediatric setting.
    Del Fante C; Scudeller L; Recupero S; Viarengo G; Boghen S; Gurrado A; Zecca M; Seghatchian J; Perotti C
    Transfus Apher Sci; 2017 Dec; 56(6):895-899. PubMed ID: 29162395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte depletion from bone marrow: performance evaluation after 50 clinical-scale depletions with Spectra Optia BMC.
    Kim-Wanner SZ; Bug G; Steinmann J; Ajib S; Sorg N; Poppe C; Bunos M; Wingenfeld E; Hümmer C; Luxembourg B; Seifried E; Bonig H
    J Transl Med; 2017 Aug; 15(1):174. PubMed ID: 28800741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red Cell Depletion of Major ABO Incompatible Bone Marrow Hematopoietic Progenitor Cells HPC(M) with the Spectra Optia®.
    Christensen A; Hsieh F; Boyer M; Couriel D; Reems JA
    Ann Clin Lab Sci; 2020 Nov; 50(6):781-789. PubMed ID: 33334794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Haemonetics Cell Saver 5+ and manual density separation for optimum depletion of red blood cells and preservation of CD34
    Qudeimat A; Zandaki D; Bi Y; Li Y; Davis K; Alloush L; Selukar S; Triplett B; Akel S; Srinivasan A
    Cytotherapy; 2023 Nov; 25(11):1145-1148. PubMed ID: 37598335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies.
    Helbig G; Stella-Holowiecka B; Wojnar J; Krawczyk M; Krzemien S; Wojciechowska-Sadus M; Markiewicz M; Wylezol I; Kopera M; Holowiecki J
    Ann Hematol; 2007 Sep; 86(9):677-83. PubMed ID: 17486341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of two protocols for optimal red blood cell depletion using Sepax-2 device for ABO-major incompatible transplantation in adults.
    Fantin L; Olivieri CV; Spirito-Daffara F; Doglio A; Olivero S
    Curr Res Transl Med; 2019 Aug; 67(3):107-111. PubMed ID: 30935875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABO-mismatched marrow processing for transplantation: Comparative results of 80 procedures performed with Cobe Spectra and Spectra Optia.
    Méndez GA; Arroyo JL; Amunárriz C; Romón Í
    Transfus Apher Sci; 2019 Jun; 58(3):326-331. PubMed ID: 31047824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double buffy coat method for red cell removal from ABO-incompatible marrow.
    Rosenfeld CS; Tedrow H; Boegel F; Gremba C; Shadduck RK
    Transfusion; 1989 Jun; 29(5):415-7. PubMed ID: 2660336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABO-incompatible pediatric bone marrow transplantation: a simple method to remove red blood cells from small volume marrow grafts.
    Chan KW; Herd SL; Stanley CE; Wadsworth LD
    Bone Marrow Transplant; 1991 Dec; 8(6):473-6. PubMed ID: 1790427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red blood cell depletion in small-volume bone marrow processing using manipulation with third-party red blood cells: A comparison of the performance of the COBE spectra and the spectra Optia systems.
    Sumii Y; Fujii N; Fujii K; Kondo T; Urata T; Kimura M; Washio K; Fujiwara H; Asada N; Ennishi D; Nishimori H; Matsuoka KI; Otsuka F; Maeda Y
    Transfusion; 2022 Sep; 62(9):1829-1838. PubMed ID: 36084209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is ABO mismatch another risk factor for allogeneic hematopoietic stem cell transplantation in pediatric thalassemic patients?
    Atay D; Erbey F; Akcay A; Ozturk G
    Pediatr Transplant; 2015 Sep; 19(6):645-51. PubMed ID: 26156679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peripheral blood stem cell collection from ABO incompatible allogeneic donors and its effect in hematopoietic stem cell transplantation].
    Xu W; Zhu M; Li YP; Bian MH; Wei YZ; Xia X; Zhang XS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1237-40. PubMed ID: 22040979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Processing of major ABO-incompatible bone marrow for transplantation by using dextran sedimentation.
    Tsang KS; Li CK; Wong AP; Leung Y; Lau TT; Li K; Shing MM; Chik KW; Yuen PM
    Transfusion; 1999; 39(11-12):1212-9. PubMed ID: 10604248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic peripheral blood stem cell transplantation using reduced-intensity conditioning in an outpatient setting in ABO-incompatible patients: are survival and graft-versus-host disease different?
    Gutiérrez-Aguirre CH; Gómez-De-León A; Alatorre-Ricardo J; Cantú-Rodríguez OG; González-Llano O; Jaime-Pérez JC; Mancías-Guerra C; Flores-Jiménez JA; Gómez-Almaguer D
    Transfusion; 2014 May; 54(5):1269-77. PubMed ID: 24898453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of ABO incompatibility on outcome after allogeneic peripheral blood stem cell transplantation.
    Kim JG; Sohn SK; Kim DH; Baek JH; Lee KB; Min WS; Kim CC; Lee MH; Lee JJ; Chung IJ; Kim HJ; Lee JW
    Bone Marrow Transplant; 2005 Mar; 35(5):489-95. PubMed ID: 15654350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of processing of bone marrow harvests for hematopoietic stem cell transplantation in pediatric patients utilizing a novel red blood cell sedimentation kit.
    Akel S; Murray C; Ferguson W; Babic A
    Transfusion; 2019 Jul; 59(7):2375-2381. PubMed ID: 31066469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red blood cell depletion from bone marrow and peripheral blood buffy coat: a comparison of two new and three established technologies.
    Sorg N; Poppe C; Bunos M; Wingenfeld E; Hümmer C; Krämer A; Stock B; Seifried E; Bonig H
    Transfusion; 2015 Jun; 55(6):1275-82. PubMed ID: 25647556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged isolated red blood cell transfusion requirement after allogeneic blood stem cell transplantation: identification of patients at risk.
    Dahl D; Hahn A; Koenecke C; Heuft HG; Dammann E; Stadler M; Buchholz S; Krauter J; Eder M; Sykora KW; Klein C; Ganser A; Sauer M
    Transfusion; 2010 Mar; 50(3):649-55. PubMed ID: 19929861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing a fully automated and closed system process for red blood cell reduction of human bone marrow products.
    Remley VA; Collins A; Underwood S; Jin J; Kim Y; Cai Y; Prochazkova M; Moses L; Byrne KM; Jin P; Stroncek DF; Highfill SL
    Cytotherapy; 2023 Apr; 25(4):442-450. PubMed ID: 36710226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of ABO-incompatibility on allogeneic hematopoietic stem cell transplantation].
    Bao L; Huang XJ; Liu KY; Xu LP; Chen H; Zhang YC; Chen YH; Han W; Lu DP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 37(2):126-9. PubMed ID: 15841137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.